CHRISTOPHER SHAWL: Open Payments
NPI 1528394574 · GREER, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$462 in 25 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $152 · 2025 $462
Food & beverage: $462
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 5 | $86 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $72 |
| Novo Nordisk Inc | 3 | $44 |
| Indivior Inc. | 2 | $44 |
| Seqirus USA Inc | 2 | $40 |
| Dexcom, Inc. | 1 | $34 |
| ABBVIE INC. | 2 | $34 |
| Vanda Pharmaceuticals Inc. | 2 | $31 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| Janssen Pharmaceuticals, Inc | 1 | $22 |
Products named: COBENFY, CAPLYTA, SUBLOCADE, Fluad, Dexcom G6 Transmitter, HETLIOZ, BEXSERO, SPRAVATO.
Industry payments across SC — which companies pay providers there.
